LONA LeonaBio, Inc.
$6.92▲ +0.58%
Healthcare
Other
After hours
$6.92▲ +0.00%
Sep 11, 7:30 PM ET
Volume 42.6K
Avg Volume (10D) 60.5K
Key Metrics & Fundamentals
Market Cap
$65.20M
P/E Ratio
–
Div Yield
–%
52W Range
3.54 - 14.21
% vs 50 MA
-11.99%
% vs 200 MA
-8.34%
RSI-14
38.0
MACD Histogram
-0.0900
Beta (1Y vs SPY)
0.80
Free Cash Flow
-$16.96M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$18.88M
COGS
–
Operating Exp
$19.28M
Operating Income
-$19.28M
EBIT
-$19.28M
Pretax Income
-$19.01M
Net Income
-$19.01M
EPS (Diluted)
-0.80
Price & Volume History
Loading chart…
Recent News
LeonaBio to Participate in Cantor Global Healthcare Conference 2026
GlobeNewswire · Sep 3, 2026 11:00 AM
LeonaBio beats Q2 loss forecast as Phase 3 ELAINE-3 trial advances
InvestorsHub · Aug 17, 2026 12:26 PM
LeonaBio Narrows Q2 Loss
MT Newswires · Aug 14, 2026 8:23 PM
LeonaBio Reports Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire · Aug 14, 2026 8:05 PM
LeonaBio to Highlight Lasofoxifene in ER-positive (ER+), HER2-negative, ESR1-mutated Metastatic Breast Cancer at DAVA Oncology’s 4th Summit on Breast Cancer
GlobeNewswire · Aug 12, 2026 11:00 AM
Immuneering Names Andrew Gengos as CFO
MT Newswires · Jun 15, 2026 12:58 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See LONA's money flow as a full page
Social Sentiment
No Reddit posts found for LONA.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.